Search for: "R&J Manufacturing Company" Results 61 - 80 of 498
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 May 2022, 12:39 pm by Ana Popovich
The company cited “four consumer complaints related to Cronobacter sakazakii or Salmonella Newport in infants who had consumed powder infant formula” manufactured in the Michigan plant” as the reason for the recall. [read post]
20 May 2022, 9:00 am by Mridu Katoch
For instance, our report reveals that some of the leading medical device and equipment manufacturers like Covidien, Philips, Siemens, Olympus, Fujifilm, Ethicon (J&J), Medtronic, Becton & Dickinson also filed for patent protection in China. [read post]
5 May 2022, 4:20 am by Emma Snell
Signup to receive the Early Edition in your inbox here. [read post]
13 Mar 2022, 4:46 pm
 On May 5, 2017, Boor, Edson, and Wildhawk entered into a confidentiality and nondisclosure agreement (“NDA”) regarding “possible R&D ‘new or enhanced product’ agreements. [read post]
22 Feb 2022, 1:50 am by Kevin Kaufman
Better cost recovery and simpler treatment for Research & Development expenses: While the U.S. leads on many R&D fronts, our advantage is in jeopardy as tax and inflation penalties on R&D investments went into effect at the start of 2022. [read post]
8 Feb 2022, 11:29 am by Geoffrey Manne
As Gaétan de Rassenfosse puts it:  SMEs can leverage their IP to facilitate R&D financing…. [read post]
14 Oct 2021, 9:03 pm by Omar Khodor
IN THE NEWS President Joseph R. [read post]
6 Oct 2021, 2:01 pm by Kevin Kaufman
MNEs to invest in research and development (R&D) in the U.S. due to reduced after-tax income from intellectual property (IP) that has been located abroad. [read post]
2 Sep 2021, 5:35 am by Kevin Kaufman
The Biden administration would require companies to deduct those costs over 39 years. [read post]
13 Jul 2021, 10:58 am by Simon Lester
                THE ESSENTIAL MEDICINES DEBATE PRIOR TO THE COVID-19 PANDEMIC The TRIPS Agreement has been the subject of intense criticism by some who allege that TRIPS subjects developing countries to the prices charged by pharmaceutical companies for essential medicines, practically denying the most vulnerable citizens of these countries access to potentially lifesaving drugs and preventing access to much cheaper… [read post]